<DOC>
	<DOC>NCT00640432</DOC>
	<brief_summary>To evaluate the safety and efficacy of celecoxib versus sodium diclofenac in subjects with acute low back pain</brief_summary>
	<brief_title>Safety And Efficacy Of Celecoxib Versus Sodium Diclofenac In The Treatment Of Acute Low Back Pain</brief_title>
	<detailed_description />
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Low Back Pain</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>Inclusion criteria: Aged between 18 and 65 years Acute low back pain that falls into 1st or 2nd class of 'Quebec Task Force' classification of moderate to severe intensity (&gt;50 mm in the VAS) Acute low back pain onset &lt;72 hours prior to study inclusion and &gt;6 weeks after the last acute low back pain episode Exclusion criteria: Scoliosis or known history of inflammatory arthritis, chronic pain, metastasis, Paget's disease, or any other disease that cause pain Low back pain from major trauma or visceral disorder Esophageal ulcers, gastric or duodenal ulcers or bleeding within 30 days prior to being administered study drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2008</verification_date>
</DOC>